Back
Intact Financial Vs. Xtacy Therapeutics Industry Stock Comparison
Buy
63
IFC.TO
Intact Financial
Last Price:
261.13
Seasonality Move:
4.44%
Sell
31
XTCY.CX
Xtacy Therapeutics
Last Price:
0.03
Seasonality Move:
-1.94%
Buy
63
Intact Financial (IFC.TO)
is a Buy
Is Intact Financial a Buy, Sell or Hold?
- The current Intact Financial [IFC.TO] share price is $259.26. The Score for IFC.TO is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- IFC.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Xtacy Therapeutics (XTCY.CX)
is a Sell
Is Xtacy Therapeutics a Buy, Sell or Hold?
- The current Xtacy Therapeutics [XTCY.CX] share price is $0.03. The Score for XTCY.CX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- XTCY.CX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IFC.TO Stock Price Chart
What is Intact Financial's stock price today?
-
The Intact Financial share price today is $259.26
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IFC.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.
XTCY.CX Stock Price Chart
What is Xtacy Therapeutics's stock price today?
-
The Xtacy Therapeutics share price today is $0.03
The current trend is relatively stagnant and XTCY.CX is experiencing slight buying pressure.
IFC.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.97 | Buy |
| Relative Strength Index (14 RSI): | 64.71 | Buy |
| Chaikin Money Flow: | 213131 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (251.38 - 255.5) | Buy |
| Bollinger Bands (100): | (227.43 - 251.13) | Buy |
XTCY.CX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 44.83 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.02 - 0.04) | Sell |
| Bollinger Bands (100): | (0.03 - 0.05) | Sell |
IFC.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 254.82 | Buy |
| 20-day SMA: | 253.66 | Buy |
| 50-day SMA: | 250.06 | Buy |
| 200-day SMA: | 227.65 | Buy |
| 8-day EMA: | 255.83 | Buy |
| 20-day EMA: | 253.98 | Buy |
| 50-day EMA: | 249.09 | Buy |
| 200-day EMA: | 230.9 | Buy |
XTCY.CX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.02 | Buy |
| 20-day SMA: | 0.03 | Sell |
| 50-day SMA: | 0.03 | Sell |
| 200-day SMA: | 0.04 | Sell |
| 8-day EMA: | 0.02 | Buy |
| 20-day EMA: | 0.03 | Sell |
| 50-day EMA: | 0.03 | Sell |
| 200-day EMA: | 0.04 | Sell |
Intact Financial Earnings Growth & IFC.TO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $2.51 per share, an increase this year of $3.50 per share, and an increase next year of $1.80 per share.
Xtacy Therapeutics Earnings Growth & XTCY.CX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Intact Financial Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Xtacy Therapeutics Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||